|
Late last month, University System of Georgia officials announced the creation
of a new academic-corporate partnership that will boost the production
of regulatory affairs professionals to support the state’s
increasing emphasis on the biosciences industry.
The University System’s Intellectual Capital Partnership Program
is administering a partnership between UGA’s College of Pharmacy
and state bioscience companies through ICAPP’s Innovations
Program. The initiative will include pharmaceutical and biotech
companies such as Cell Dynamics, Ciba Vision, CR Bard, Cryolife,
Serologicals, Pharmaceuticals and UCB Pharma, who are joining with
ICAPP to cover the program’s costs.
After earning graduate-level certificates that can lead to master
of science degrees, program graduates will fill vital bioscience
regulatory positions.
“In Georgia, we help existing companies grow by asking what
they need, listening to their responses and reacting accordingly,”
says Gov. Sonny Perdue. “ICAPP continues to help our state
meet the high-tech workforce needs of current and potential employers
by enabling us to act quickly to meet the demand for well-prepared
college graduates.”
Initially, the new ICAPP initiative will spur the creation of 50
jobs in the regulatory affairs industry, which includes the areas
of quality control and quality assurance.
These highly educated employees will play a vital role in the manufacturing
and testing of pharmaceuticals, medical devices, biologics and biotechnology.
“The University System of Georgia is proud to help realize
Gov. Perdue’s vision of Georgia becoming a key player in the
biosciences sector,” says Chancellor Thomas C. Meredith. “ICAPP
has an excellent track record of innovative partnering to meet the
needs of business and industry. This new bioscience initiative promises
to help Georgia create yet another successful economic development
niche.”
|
